We use only the highest-quality ingredients, sourced in the USA, and rigorously tested for purity.
There are 3,673 studies on piracetam and counting.
Piracetam is also known as 2-Pyrrolidone-N-Acetamide.
Piracetam is also known as 2-Pyrrolidone-N-Acetamide.
We are obsessed with quality control. All our ingredients are sourced from the USA and tested by independent third party labs to ensure purity. You can view the test results in our Certificate of Analysis.
Developed in Europe during the 1960’s, piracetam has become one of the world’s most well known and extensively studied nootropics. Piracetam belongs to a small nootropic group called “racetams”, which each have cognitive enhancing properties. Since the discovery of Piracetam, researchers have discovered a wide variety of treatments and benefits of the nootropic. It has been used to successfully treat and repair cognitive impairment in brain trauma patients, improve visuomotor skills, and boost memory.
“As I get older, I’m having issues staying focused. In my work life, emergencies happen unexpectedly and it’s on me to develop plans quickly. I notice my brain is no longer scattered when these critical moments come up. Since starting to use (Piracetam) daily, I notice my vision and hearing are sharper and I’m recalling important details.” - Janet W.
Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents.
Piracetam inhibits ethanol (EtOH)-induced memory deficit by mediating multiple pathways.
A study to evaluate the effect of nootropic drug-piracetam on DNA damage in leukocytes and macrophages.
Effect of piracetam on cognitive performance in patients undergoing bypass surgery.
A systematic review and meta-analysis of the efficacy of piracetam and piracetam-like compounds in experimental stroke.
Improvement of mitochondrial function and dynamics by the metabolic enhancer piracetam.
Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placebo.
Long-term Efficacy and Safety of Piracetam in the Treatment of Progressive Myoclonus Epilepsy
Effect of piracetam on the color discriminative function of retina in patients with craniocerebral trauma
Experience of the out-patient use of memotropil in the treatment of cognitive disorders in patients with chronic progressive cerebrovascular disorders
Evaluation of effect of piracetam in experimental models of depression